Adriann Sax

Adriann Sax

Fondatore presso
Vetigenics LLC
65 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Adriann W.
Sax
is the founder of Vetigenics LLC, serving as President, Chief Executive Officer & Director since 2017.
Former positions include Chief Executive Officer & Director at Orsenix LLC from 2019 to 2020, Executive Director-Oncology at Merck & Co., Inc., Director at Healthcare Businesswomen Association, Independent Director at QSAM Biosciences, Inc. from 2022 to 2024, Vice President-Marketing at Bristol Myers Squibb Co., EVP-Business Development & Strategic Planning at KP Pharmaceuticals LLC, Principal at Sterling Drug, Inc., Chief Business Officer at Symphogen A, Principal at Roche Laboratories, Inc., and Chief Commercial Officer & Executive VP at Kadmon Corp.
LLC.
Education includes an undergraduate degree from the University of Delaware and an MBA from Keller Graduate School of Management.

Posizioni attive di Adriann Sax

SocietàPosizioneInizio
Fondatore 01/01/2017

Precedenti posizioni note di Adriann Sax

SocietàPosizioneFine
Direttore/Membro del Consiglio 02/05/2024
Amministratore Delegato 01/01/2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Adriann Sax

Formazione di Adriann Sax

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

9

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Non-Durables

Consumer Services

Health Technology

Distribution Services

Consumer Services

Health Technology

Process Industries

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Adriann Sax